Chicago Atlantic Real Estate Finance, Inc. (REFI)

Chicago Atlantic Real Estate Finance, Inc. is a mortgage real estate investment trust — a REIT — that makes first mortgage loans to cannabis operators in the United States. The company trades on the NASDAQ under the ticker REFI and was formed in 2021 as a specialized lender in one of the most fragmented and capital-constrained sectors of the American economy.

The capital structure of cannabis lending in America is unusual and worth understanding. Cannabis remains prohibited under federal law, even though more than two dozen states have legalized it for medical and recreational use. This federal prohibition creates a financing desert. Banks cannot lend to cannabis businesses because doing so would expose them to federal anti-money-laundering penalties and other regulatory risks. Traditional sources of capital — public stock markets, investment banks, venture capital — largely avoid the space. Cannabis operators therefore face a severe shortage of institutional capital, particularly for real estate acquisition and working capital.

Chicago Atlantic emerged to serve precisely this gap. The company originated from and is backed by the cannabis lending platform of a larger institutional investor that had already sourced and closed over two billion dollars in credit facilities to cannabis operators since 2019. When Chicago Atlantic spun out as a standalone REIT, it inherited that origination infrastructure, the relationships, and the deep cannabis credit expertise — a competitive moat that more general commercial lenders cannot quickly replicate.

The lending thesis

Chicago Atlantic focuses exclusively on first mortgage loans — senior-ranked debt secured by cannabis-related real estate. This positioning is deliberate. A first mortgage has priority claim on the property if the borrower defaults, which reduces the lender’s loss severity. The company targets established operators, typically multi-state or single-state cannabis businesses with professional management, proven operating track records, and strong balance sheets relative to the typical cannabis operator.

Underwriting is credit-first: the company evaluates the borrower’s operational strength, profitability, regulatory standing, and capacity to service debt. It examines the real estate collateral separately. And it assesses the regulatory and market environment in each state — whether licensing is competitive, whether supply is constrained or saturated, whether the operator has defensible market share. This discipline matters because cannabis lending is not uniform: some borrowers and markets are materially safer than others.

The borrower population is nascent but growing in sophistication. Early cannabis entrepreneurs were often self-funded or venture-backed. Today, as the industry matures, professional operators with finance expertise are consolidating market share, building multi-state empires, and accessing institutional capital where they can. Chicago Atlantic targets this cohort because they are creditworthy and can consistently service debt.

Returns, capital structure, and REIT mechanics

Chicago Atlantic, like all REITs, must distribute most of its taxable income to shareholders as dividends. This is the tax trade-off of the REIT structure: the company pays no federal corporate tax as long as it distributes at least 90 percent of net income to shareholders, and shareholders pay tax on those distributions. The incentive is to maximize the spread between the interest rate charged to borrowers and the cost of capital the REIT raises — the difference flows to dividends.

The company funds its lending through two channels: equity capital raised from shareholders, and debt it issues or arranges. The equity capital is the REIT’s buffer — the loss-absorbing layer if borrower defaults are higher than expected. The debt is the leverage that lets the REIT amplify returns on equity. A typical REIT might leverage its equity capital three or four to one, borrowing three to four dollars for every dollar shareholders provide, then deploying that capital into loans that yield more than the cost of borrowing.

Chicago Atlantic’s ability to raise capital at reasonable cost depends on lender confidence in the cannabis credit thesis and in the company’s ability to source and underwrite good loans. Capital markets — the buyers of REIT debt and equity — are sophisticated but fickle. If cannabis lending hits unexpected losses, or if regulators tighten rules around cannabis, capital could become expensive or unavailable, and a REIT suddenly cannot originate new loans or refinance maturing debt.

The federal prohibition as a moat and a ceiling

Chicago Atlantic’s business is possible precisely because federal prohibition makes cannabis lending high-risk. Normal lenders avoid it. That avoidance creates the pricing opportunity — cannabis borrowers must pay more for capital than mainstream borrowers would, and Chicago Atlantic captures the spread. The moat is that the company has the expertise, the relationships, and the institutional backing to win this business.

But the prohibition is also a ceiling. If federal prohibition were lifted and cannabis became a legal, bankable industry, suddenly Chicago Atlantic would compete against every regional and national bank, all of which would undercut its pricing to gain market share. The company would likely lose its informational and relationship advantages overnight. This dynamic means Chicago Atlantic’s long-term value depends implicitly on cannabis remaining federally illegal — a perverse but real aspect of the capital structure. If legalization happened, the company would need to either find a new niche or face margin compression and declining returns.

Additionally, Chicago Atlantic faces state-level regulatory risk. States can revoke licenses, cap the number of dispensaries, impose new taxes, or change zoning rules, any of which can crater borrower profitability and loan performance. The company cannot diversify away this risk entirely because its entire portfolio is cannabis loans in limited-license states. It can only manage it through careful borrower and state selection.

Loan portfolio and risk management

Chicago Atlantic’s loans are geographically diversified across multiple limited-license states — jurisdictions that restrict the number of cannabis licenses to maintain scarcity and support operator profitability. Limited licenses are preferable to unlimited-license states where oversupply crushes margins and borrower creditworthiness declines. The company focuses on operators with established market presence and regulatory relationships in these states.

The portfolio includes first mortgage loans of varying sizes. Typical loans might be $5 million to $20 million, secured by cultivation facilities, retail storefronts, or processing operations. The company underwrites to loan-to-value ratios — lending perhaps 60 to 70 percent of the appraised value of the underlying real estate — to preserve a margin of safety if collateral value declines or borrower troubles emerge.

Loan performance is central to the investment thesis. If default rates are low and loan losses are manageable, Chicago Atlantic generates the spread between its borrowing cost and its lending yield, converts most of that to dividends, and shareholders enjoy steady cash income. If defaults spike, loan loss reserves must be taken, earnings decline, and dividend capacity shrinks. The company publishes quarterly reports detailing its loan portfolio, delinquencies, and loss experience, allowing investors to track credit trends in real time.

Capital raise and future growth

Chicago Atlantic was formed in 2021, so it is a young company operating in a still-young industry. To originate more loans and grow assets, it must raise more capital — issuing equity to shareholders or borrowing from debt markets. The equity raise is dilutive to existing shareholders but brings in capital at prices investors will pay. The debt raise is cheaper (because interest is tax-deductible for the REIT) but increases financial risk.

The company trades at prices set by the market, which reflects investors’ views on cannabis lending returns and cannabis regulatory risk. If federal legalization suddenly seemed imminent, Chicago Atlantic’s stock would likely fall sharply because the moat would be crumbling. Conversely, if cannabis banking restrictions tightened and the financing gap widened, the company might find itself with strong demand for its capital and the ability to deploy it at higher spreads, boosting returns.

Understanding the investment

Anyone studying Chicago Atlantic should begin with its quarterly reports on SEC Form 10-Q and annual 10-K filing (CIK 0001867949), both of which provide detailed portfolio breakdowns by state, borrower type, loan size, and collateral. Specific metrics to watch are the company’s loan-to-value ratios, average loan size, concentration in any single state or borrower, delinquency rates, and the trailing twelve-month yield on loans compared to the company’s cost of capital.

The fundamentals of the business are straightforward: a cannabis borrower applies for a loan to buy real estate, Chicago Atlantic structures a first mortgage at a spread to its cost of capital, collects interest and principal over time, and distributes profits to shareholders. The risks are also clear: federal policy changes that legalize cannabis, state regulatory changes that harm borrower profitability, or a recession that reduces cannabis consumer demand and borrower cash flow. Investors must weigh the attractive current yields against the regulatory and policy tail risks inherent in being a lender to an industry operating at the margin of federal law.